Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Dhawale TM"'
Autor:
Dhawale TM; Department of Medicine, Division of Hematology and Oncology, Massachusetts General Hospital, Boston, MA, United States.; Harvard Medical School, Boston, MA, United States., Bhat RS; University of Colorado School of Medicine, Aurora, CO, United States., Johnson PC; Department of Medicine, Division of Hematology and Oncology, Massachusetts General Hospital, Boston, MA, United States.; Harvard Medical School, Boston, MA, United States., Srikonda S; Harvard University, Boston, MA, United States., Lau-Min KS; Department of Medicine, Division of Hematology and Oncology, Massachusetts General Hospital, Boston, MA, United States.; Harvard Medical School, Boston, MA, United States., Boateng K; Department of Medicine, Division of Hematology and Oncology, Massachusetts General Hospital, Boston, MA, United States., Lee H; Division of Hematology &Oncology, University of California San Francisco, San Francisco, CA, United States., Amonoo HL; Harvard Medical School, Boston, MA, United States.; Department of Psychiatry, Brigham and Women's Hospital, Boston, MA, United States.; Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute, Boston, MA, United States., Nipp R; Section of Hematology/Oncology, Department of Internal Medicine, University of Oklahoma Health Sciences Center, Stephenson Cancer Center, Oklahoma City, OK, United States., Lindvall C; Harvard Medical School, Boston, MA, United States.; Clinical Informatics, Dana Farber Cancer Institute, Boston, MA, United States., El-Jawahri A; Department of Medicine, Division of Hematology and Oncology, Massachusetts General Hospital, Boston, MA, United States.; Harvard Medical School, Boston, MA, United States.
Publikováno v:
The oncologist [Oncologist] 2024 Aug 29. Date of Electronic Publication: 2024 Aug 29.
Autor:
Dhawale TM; Cancer Center, Massachusetts General Hospital, Boston, Massachusetts, USA.; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA., Johnson PC; Cancer Center, Massachusetts General Hospital, Boston, Massachusetts, USA.; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA., Gaballa MR; Cancer Center, Massachusetts General Hospital, Boston, Massachusetts, USA.; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA., Nelson AM; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.; Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts, USA., Lavoie MW; Cancer Center, Massachusetts General Hospital, Boston, Massachusetts, USA., Boateng KY; Cancer Center, Massachusetts General Hospital, Boston, Massachusetts, USA., Greydanus C; Cancer Center, Massachusetts General Hospital, Boston, Massachusetts, USA., Frigault MJ; Cancer Center, Massachusetts General Hospital, Boston, Massachusetts, USA.; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA., El-Jawahri A; Cancer Center, Massachusetts General Hospital, Boston, Massachusetts, USA.; Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.
Publikováno v:
Cancer [Cancer] 2023 Feb 01; Vol. 129 (3), pp. 441-449. Date of Electronic Publication: 2022 Dec 01.
Autor:
Amonoo HL; Department of Psychiatry, Brigham and Women's Hospital.; Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute, and.; Harvard Medical School, Boston, Massachusetts., Daskalakis E; Department of Psychiatry, Brigham and Women's Hospital., Deary EC; Department of Psychiatry, Brigham and Women's Hospital., Bodd MH; Duke University School of Medicine, Durham, North Carolina., Reynolds MJ; Division of Hematology and Oncology, Department of Medicine, and., Nelson AM; Harvard Medical School, Boston, Massachusetts.; Department of Psychiatry, Massachusetts General Hospital, Boston, Massachusetts., Newcomb R; Division of Hematology and Oncology, Department of Medicine, and., Dhawale TM; Division of Hematology and Oncology, Department of Medicine, and., Yang D; Division of Hematology and Oncology, Department of Medicine, and., Luger SM; Division of Hematology Oncology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania., Gustin JL; Division of Palliative Medicine, The James Cancer Hospital, Ohio State University, Columbus, Ohio; and., Brunner A; Harvard Medical School, Boston, Massachusetts.; Division of Hematology and Oncology, Department of Medicine, and., Fathi AT; Harvard Medical School, Boston, Massachusetts.; Division of Hematology and Oncology, Department of Medicine, and., LeBlanc TW; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University School of Medicine, Durham, North Carolina., El-Jawahri A; Harvard Medical School, Boston, Massachusetts.; Division of Hematology and Oncology, Department of Medicine, and.
Publikováno v:
Journal of the National Comprehensive Cancer Network : JNCCN [J Natl Compr Canc Netw] 2022 Oct; Vol. 20 (10), pp. 1116-1123.
Autor:
Amonoo HL; Department of Psychiatry, Brigham and Women's Hospital, Boston, MA.; Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA., Bodd MH; Division of Hematology and Oncology, Department of Medicine, Duke University School of Medicine, Durham, NC; and., Reynolds MJ; Division of Hematology and Oncology, Department of Medicine, and., Nelson AM; Harvard Medical School, Boston, MA.; Department of Psychiatry, Massachusetts General Hospital, Boston, MA., Newcomb R; Division of Hematology and Oncology, Department of Medicine, and., Johnson PC; Division of Hematology and Oncology, Department of Medicine, and., Dhawale TM; Division of Hematology and Oncology, Department of Medicine, and., Plotke R; Division of Hematology and Oncology, Department of Medicine, and., Heuer L; Division of Hematology and Oncology, Department of Medicine, and., Gillani S; Division of Hematology and Oncology, Department of Medicine, and., Yang D; Division of Hematology and Oncology, Department of Medicine, and., Deary EC; Department of Psychiatry, Brigham and Women's Hospital, Boston, MA., Daskalakis E; Department of Psychiatry, Brigham and Women's Hospital, Boston, MA., Goldschen L; Department of Psychiatry, Brigham and Women's Hospital, Boston, MA., Brunner A; Harvard Medical School, Boston, MA.; Division of Hematology and Oncology, Department of Medicine, Duke University School of Medicine, Durham, NC; and.; Division of Hematology and Oncology, Department of Medicine, and., Fathi AT; Harvard Medical School, Boston, MA.; Division of Hematology and Oncology, Department of Medicine, and., LeBlanc TW; Division of Hematology and Oncology, Department of Medicine, Duke University School of Medicine, Durham, NC; and., El-Jawahri A; Harvard Medical School, Boston, MA.; Division of Hematology and Oncology, Department of Medicine, Duke University School of Medicine, Durham, NC; and.; Division of Hematology and Oncology, Department of Medicine, and.
Publikováno v:
Blood advances [Blood Adv] 2022 Apr 12; Vol. 6 (7), pp. 2435-2442.
Autor:
Johnson PC; Department of Medicine, Division of Hematology & Oncology, Massachusetts General Hospital, Boston, Massachusetts; Harvard Medical School, Boston Massachusetts. Electronic address: pcjohnson@mgh.harvard.edu., Bhatt S; Department of Medicine, Division of Hematology & Oncology, Massachusetts General Hospital, Boston, Massachusetts., Reynolds MJ; Department of Psychiatry, Massachusetts General Hospital & Harvard Medical School, Boston, Massachusetts., Dhawale TM; Department of Medicine, Division of Hematology & Oncology, Massachusetts General Hospital, Boston, Massachusetts; Harvard Medical School, Boston Massachusetts., Ufere N; Harvard Medical School, Boston Massachusetts; Department of Medicine, Division of Gastroenterology, Massachusetts General Hospital, Boston, Massachusetts., Jagielo AD; Department of Psychiatry, Massachusetts General Hospital & Harvard Medical School, Boston, Massachusetts., Lavoie MW; Department of Psychiatry, Massachusetts General Hospital & Harvard Medical School, Boston, Massachusetts., Topping CEW; Department of Psychiatry, Massachusetts General Hospital & Harvard Medical School, Boston, Massachusetts., Clay MA; Department of Psychiatry, Massachusetts General Hospital & Harvard Medical School, Boston, Massachusetts., Rice J; Department of Psychiatry, Massachusetts General Hospital & Harvard Medical School, Boston, Massachusetts., Yi A; Department of Medicine, Division of Hematology & Oncology, Massachusetts General Hospital, Boston, Massachusetts., DeFilipp Z; Department of Medicine, Division of Hematology & Oncology, Massachusetts General Hospital, Boston, Massachusetts; Harvard Medical School, Boston Massachusetts., Chen YB; Department of Medicine, Division of Hematology & Oncology, Massachusetts General Hospital, Boston, Massachusetts; Harvard Medical School, Boston Massachusetts., El-Jawahri A; Department of Medicine, Division of Hematology & Oncology, Massachusetts General Hospital, Boston, Massachusetts; Harvard Medical School, Boston Massachusetts.
Publikováno v:
Transplantation and cellular therapy [Transplant Cell Ther] 2021 Jun; Vol. 27 (6), pp. 496.e1-496.e5. Date of Electronic Publication: 2021 Feb 25.
Autor:
Amonoo HL; Brigham and Women's Hospital, Boston, Massachusetts.; Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts., Johnson PC; Harvard Medical School, Boston, Massachusetts.; Massachusetts General Hospital, Boston, Massachusetts., Dhawale TM; Harvard Medical School, Boston, Massachusetts.; Massachusetts General Hospital, Boston, Massachusetts., Traeger L; Harvard Medical School, Boston, Massachusetts.; Massachusetts General Hospital, Boston, Massachusetts., Rice J; Massachusetts General Hospital, Boston, Massachusetts., Lavoie MW; Massachusetts General Hospital, Boston, Massachusetts., Ufere NN; Harvard Medical School, Boston, Massachusetts.; Massachusetts General Hospital, Boston, Massachusetts., Longley RM; Massachusetts General Hospital, Boston, Massachusetts., Harnedy LE; Massachusetts General Hospital, Boston, Massachusetts., Clay MA; Massachusetts General Hospital, Boston, Massachusetts., Topping CEW; Massachusetts General Hospital, Boston, Massachusetts., DeFilipp Z; Harvard Medical School, Boston, Massachusetts.; Massachusetts General Hospital, Boston, Massachusetts., Chen YA; Harvard Medical School, Boston, Massachusetts.; Massachusetts General Hospital, Boston, Massachusetts., El-Jawahri A; Harvard Medical School, Boston, Massachusetts.; Massachusetts General Hospital, Boston, Massachusetts.
Publikováno v:
Cancer [Cancer] 2021 Apr 15; Vol. 127 (8), pp. 1260-1265. Date of Electronic Publication: 2021 Feb 17.
Autor:
Johnson PC; 1Department of Medicine, Division of Hematology & Oncology, Massachusetts General Hospital Cancer Center & Harvard Medical School., Jacobson C; 2Department of Medical Oncology, Center for Lymphoma, Dana-Farber Cancer Institute & Harvard Medical School; and., Yi A; 1Department of Medicine, Division of Hematology & Oncology, Massachusetts General Hospital Cancer Center & Harvard Medical School., Saucier A; 2Department of Medical Oncology, Center for Lymphoma, Dana-Farber Cancer Institute & Harvard Medical School; and., Dhawale TM; 1Department of Medicine, Division of Hematology & Oncology, Massachusetts General Hospital Cancer Center & Harvard Medical School., Nelson A; 3Department of Psychiatry, Massachusetts General Hospital & Harvard Medical School, Boston, Massachusetts., Lavoie MW; 3Department of Psychiatry, Massachusetts General Hospital & Harvard Medical School, Boston, Massachusetts., Reynolds MJ; 3Department of Psychiatry, Massachusetts General Hospital & Harvard Medical School, Boston, Massachusetts., Topping CEW; 3Department of Psychiatry, Massachusetts General Hospital & Harvard Medical School, Boston, Massachusetts., Frigault MJ; 1Department of Medicine, Division of Hematology & Oncology, Massachusetts General Hospital Cancer Center & Harvard Medical School., El-Jawahri A; 1Department of Medicine, Division of Hematology & Oncology, Massachusetts General Hospital Cancer Center & Harvard Medical School.
Publikováno v:
Journal of the National Comprehensive Cancer Network : JNCCN [J Natl Compr Canc Netw] 2021 Mar 11; Vol. 19 (8), pp. 928-934. Date of Electronic Publication: 2021 Mar 11.
Autor:
Hirayama AV; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA., Gauthier J; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA., Hay KA; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA.; Department of Medicine, University of British Columbia, Vancouver, BC, Canada., Voutsinas JM; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA., Wu Q; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA., Gooley T; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA., Li D; Juno Therapeutics, Seattle, WA; and., Cherian S; Department of Laboratory Medicine and., Chen X; Department of Laboratory Medicine and., Pender BS; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA., Hawkins RM; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA., Vakil A; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA., Steinmetz RN; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA., Acharya UH; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA.; Department of Medicine, University of Washington, Seattle, WA., Cassaday RD; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA.; Department of Medicine, University of Washington, Seattle, WA., Chapuis AG; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA.; Department of Medicine, University of Washington, Seattle, WA., Dhawale TM; Department of Medicine, University of Washington, Seattle, WA., Hendrie PC; Department of Medicine, University of Washington, Seattle, WA., Kiem HP; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA.; Department of Medicine, University of Washington, Seattle, WA., Lynch RC; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA.; Department of Medicine, University of Washington, Seattle, WA., Ramos J; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA.; Department of Medicine, University of Washington, Seattle, WA., Shadman M; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA.; Department of Medicine, University of Washington, Seattle, WA., Till BG; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA.; Department of Medicine, University of Washington, Seattle, WA., Riddell SR; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA.; Department of Medicine, University of Washington, Seattle, WA., Maloney DG; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA.; Department of Medicine, University of Washington, Seattle, WA., Turtle CJ; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA.; Department of Medicine, University of Washington, Seattle, WA.
Publikováno v:
Blood [Blood] 2019 Apr 25; Vol. 133 (17), pp. 1876-1887. Date of Electronic Publication: 2019 Feb 19.
Autor:
Dhawale TM; Department of Medicine, University of Washington School of Medicine, SCCA, 825 Eastlake Avenue East, M-Box G3-200, Seattle, WA 98109, USA., Shustov AR; Department of Medicine, University of Washington School of Medicine, SCCA, 825 Eastlake Avenue East, M-Box G3-200, Seattle, WA 98109, USA. Electronic address: ashustov@seattlecca.org.
Publikováno v:
Hematology/oncology clinics of North America [Hematol Oncol Clin North Am] 2017 Apr; Vol. 31 (2), pp. 335-357.